Skip to main content

Table 4 Concomitant use with other nephrotoxic medications

From: The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study

Nephrotoxic Medication (s) Early Late P-value
Flucloxacillin IV, n (%) 1 (1.3) 2 (2.6) 0.5754**
Amikacin IV, n (%) 7 (9.2) 5 (6.5) 0.5320^^
Gentamicin IV, n (%) 12 (15.6) 18 (21.7) 0.3231^^
Colistin IV, n (%) 9 (11.8) 10 (12.8) 0.8536^^
Piperacillin/tazobactam IV, n (%) 63 (63.6) 68 (66.0) 0.7229^^
Sulfamethoxazole/trimethoprim IV, n (%) 3 (4.0) 9 (11.1) 0.0958^^
Furosemide IV, n (%) 61 (59.8) 52 (55.3) 0.5255^^
IV Contrast, n (%) 35 (33.7) 40 (38.5) 0.4703^^
  1. ^^Chi-square test is used to calculate the P-value
  2. **Fisher Exact test is used to calculate the P-value